Press Releases

  • June 16, 2020

    Nemaura Participated as Guest Speaker at DiabetesMine™ D-Data ExChange 2020

    LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based...

    June 10, 2020

    Nemaura Medical to Present at Credit Suisse 2020 Virtual Diabetes Sessions

    Loughborough, England, June 9, 2020 — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company...

    June 9, 2020

    Nemaura Medical Set to Join the Russell 2000® Index and Russell 3000® Index

    Loughborough, England, June 9, 2020 — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company...

    May 19, 2020

    Nemaura Medical 2020 Stock Incentive Plan Approved at Annual General Meeting

    Loughborough, England, May 19, 2020 — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company...

    May 11, 2020

    Nemaura reports positive data from early head-to-head comparison with a major incumbent CGM Device

    sugarBEAT® was developed as a viable, flexible, and cost-effective alternative to invasive continuous glucose monitors (“CGM”), and the company...

    May 5, 2020

    Nemaura Medical Announces Interview with CEO to Air on May 11

    Loughborough, England, May 5, 2020 — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company...

    April 21, 2020

    Nemaura Secures $5 Million Loan to Accelerate Commercial Strategy

    Loughborough, England, April 21, 2020 — Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company...

    April 1, 2020

    Nemaura Plans To Launch Body-Worn Continuous Temperature Monitor (CTM) to Track Fever Caused by Viral Infections such as COVID-19

    BEAT® platform is planned to be extended to conditions requiring continuous temperature monitoring including viral infections and poor blood...

    March 10, 2020

    Nemaura Medical enters into multiple verbal non-binding agreements for its sugarBEAT® platform

    sugarBEAT® strategic global partnership(s) a step closer as Nemaura Medical enters into multiple verbal non-binding agreements Loughborough, England, March...